英文名称 | 中文名称 | CAS | MF |
rmMIG
|
rmMIG
|
|
|
701RNCH 10UL SYR (26S/2"/2)
|
|
|
|
rmMIP-1a
|
重组小鼠MACROPHAGE INFLAMMATORY蛋白1 ALPHA / CCL3
|
|
|
rmMIP-3b
|
|
|
|
rmMIP-1b
|
|
|
|
rmMIP-b
|
|
|
|
(R)-N-Butyl-8-ethoxy-1,4-benzodioxane-2-methanamine
|
|
|
C15H23NO3
|
R-N-BUTYL-2-PHENYLETHANAMINE
|
|
|
C12H19N
|
(R)-4-N-BUTOXYCARBONYL-2-METHYLPIPERAZINE
|
|
|
C10H20N2O2
|
(4R)-N-(1-BUTYLDIMETHYLSILYL)AZETIDIN-2-ONE-4-CARBOXYLIC ACID
|
|
|
C10H19NO3Si
|
rMMLV-RT
|
|
|
|
(R)-N-Deacetyl Colchicine
|
(+)-N-去乙酰基秋水仙碱
|
102419-91-0
|
C20H23NO5
|
(R)-N-Deacetyl Colchicine d-10-CaMphorsulfonate
|
(+)-N-去乙酰基秋水仙碱 D-樟脑磺酸盐
|
102419-97-6
|
C30H40N2O8S
|
(R)-N-DeMethyl Dapoxetine
|
达泊西汀杂质
|
1202160-36-8
|
C20H21NO
|
[R,(+)]-N-[2-[(3,5-Dibromophenyl)sulfamoyl]ethyl]-2,4-dihydroxy-3,3-dimethylbutyramide
|
|
|
C14H20Br2N2O5S
|
(R)-1,4-N-Diboc-2-piperazine-2-carboxylic acid
|
|
|
|
1-[(R)-2-[N-(3,4-Dichlorophenylacetyl)-N-methylamino]propyl]pyrrolidinium
|
|
|
C16H23Cl2N2O+
|
1-[(R)-2-[N-(3,4-Dichlorophenylacetyl)-N-methylamino]-1-methylethyl]pyrrolidinium
|
|
|
C16H23Cl2N2O+
|
(1R)-N-(3,4-Dichlorophenyl)-1,2,3,4,4a,5,6,7,8,9,10,10a-dodecahydro-7-isopropyl-1,4a-dimethylphenanthrene-1α-carboxamide
|
|
|
|
(1R)-N-(2,4-Dichlorophenyl)-1,2,3,4,4a,5,6,7,8,9,10,10a-dodecahydro-7-isopropyl-1,4a-dimethylphenanthrene-1α-carboxamide
|
|
|
|
1-[(R)-2-[N-(3,4-Dichlorophenylacetyl)-N-methylamino]1,1-dimethylpropyl]pyrrolidinium
|
|
|
C18H27Cl2N2O+
|
(R)-N-(3,5-Dichlorophenyl)-2-hydroxysuccinamidic acid
|
|
|
|
1-[(R)-2-[N-(3,4-Dichlorophenylacetyl)-N-methylamino]-1,2-dimethylpropyl]pyrrolidinium
|
|
|
C18H27Cl2N2O+
|
(1R)-N-(2,6-Dichlorophenyl)-1,2,3,4,4a,5,6,7,8,9,10,10a-dodecahydro-7-isopropyl-1,4a-dimethylphenanthrene-1α-carboxamide
|
|
|
|
(R)-N-(3,5-Dichlorophenyl)-3-hydroxysuccinamidic acid
|
|
|
|
R-N-(3,5-DICHLOROPHENYL)-2-HYDROXYSUCCINAMICACID
|
|
|
C10H9Cl2NO4
|
(R)-N-DideMethyl Dapoxetine
|
达泊西汀杂质
|
1329834-62-9
|
C19H19NO
|
[R,(+)]-N-(3,3-Diethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutyramide
|
|
|
C13H27NO5
|
(1R)-N-(2,6-Diethylphenyl)-1,2,3,4,4a,5,6,7,8,9,10,10a-dodecahydro-7-isopropyl-1,4a-dimethylphenanthrene-1α-carboxamide
|
|
|
|
(R)-N-[2-(Diethylamino)ethyl]-α-methyl-[1,1'-biphenyl]-4-acetamide
|
|
|
|
(R)-N-(2,2-DIFLUOROETHYLIDENE)-1-PHENYLETHYLAMINE
|
(R)-N-(2,2-二氟亚乙基)-1-苯乙胺
|
160797-29-5
|
C10H11F2N
|
(R)-N-(1,4-dihydroxybutan-2-yl)benzamide
|
(R)-N-(1,4-dihydroxybutan-2-yl)benzamide
|
1245643-19-9
|
C11H15NO3
|
(R)-N-(1,5-dihydroxypentan-2-yl)benzamide
|
(R)-N-(1,5-二羟基戊-2-基)苯甲酰胺
|
1245648-10-5
|
C12H17NO3
|
Sodium D-pantothenate
|
D-泛酸钠
|
867-81-2
|
C9H16NNaO5
|
(R)-N-[2,3-DIHYDRO-1-[2-(2-METHYLPHENYL)-2-OXOETHYL]-2-OXO-5-PHENYL-1H-1,4-BENZODIAZEPIN-3-YL]-N'-(3-METHYLPHENYL)-UREA
|
(R)-N-[2,3-DIHYDRO-1-[2-(2-METHYLPHENYL)-2-OXOETHYL]-2-OXO-5-PHENYL-1H-1,4-BENZODIAZEPIN-3-YL]-N'-(3-METHYLPHENYL)-UREA
|
145084-28-2
|
C32H28N4O3
|
(R)-N-(2,4-dihydroxy-3,3-dimethylbutyryl)-beta-alanine, magnesium salt
|
|
65135-27-5
|
C18H32MgN2O10
|
(1R)-N-(2,6-Diisopropylphenyl)-1,2,3,4,4a,5,6,7,8,9,10,10a-dodecahydro-7-isopropyl-1,4a-dimethylphenanthrene-1α-carboxamide
|
|
|
|
(2R)-N-(2,6-DIMETHYLPHENYL)-2-PIPERIDINECARBOXAMIDE
|
N-去丙基-(R)-罗哌卡因
|
27262-43-7
|
C14H20N2O
|
(1R)-N-(2,5-Dimethoxyphenyl)-1,2,3,4,4a,5,6,7,8,9,10,10a-dodecahydro-7-isopropyl-1,4a-dimethylphenanthrene-1α-carboxamide
|
|
|
|
(1R)-N,1-Dimethyl-2-(4-hydroxyphenyl)ethanamine
|
|
|
C10H15NO
|
(2R)-N-(2,6-Dimethylphenyl)-1-(2-hydroxyethyl)-2β-piperidinecarboxamide
|
|
|
|
(1R)-N-(2,6-Dimethylphenyl)-1,2,3,4,4a,9,10,10a-octahydro-7-isopropyl-1,4a-dimethylphenanthrene-1α-carboxamide
|
|
|
|
(1R)-N-(2,5-Dimethylphenyl)-1,2,3,4,4a,5,6,7,8,9,10,10a-dodecahydro-7-isopropyl-1,4a-dimethylphenanthrene-1α-carboxamide
|
|
|
|
[R,(-)]-N,3-Dimethyl-2-phenylbutyramide
|
|
|
C12H17NO
|
(1R)-N-(3,5-Dimethylphenyl)-1,2,3,4,4a,5,6,7,8,9,10,10a-dodecahydro-7-isopropyl-1,4a-dimethylphenanthrene-1α-carboxamide
|
|
|
|
(1R)-N-(2,6-Dimethylphenyl)-1,2,3,4,4a,5,6,7,8,9,10,10a-dodecahydro-7α-ethyl-1,4a,7-trimethylphenanthrene-1α-carboxamide
|
|
|
|
[R,(-)]-N,2-Dimethyl-β-alanine methyl ester
|
|
|
|
(2R)-N,3-Dimethyl-N-formyl-2-[methyl[(R)-4-methyl-2-[methyl[[methyl(1-oxodecyl)amino]acetyl]amino]valeryl]amino]butyramide
|
|
|
C28H52N4O5
|
[R,(-)]-N,2-Dimethylbutyramide
|
|
|
C6H13NO
|
[R,(-)]-N,3-Dimethyl-2-phenylthiobutyramide
|
|
|
C12H17NS
|
(1R)-N-(2,3-Dimethylphenyl)-1,2,3,4,4a,5,6,7,8,9,10,10a-dodecahydro-7-isopropyl-1,4a-dimethylphenanthrene-1α-carboxamide
|
|
|
|
[R,(-)]-N,2-Dimethylthiobutyramide
|
|
|
C6H13NS
|
[3R,(-)]-N-(2,2-Dimethylpropylidene)-3-(dimethoxymethyl)-D-glutamic acid dimethyl ester
|
|
|
C15H27NO6
|
[αR,(+)]-N,α-Dimethyl-N-benzylbenzeneethanamine
|
|
|
|
[2R,(-)]-N,2-Dimethyl-N-nitrosobutyramide
|
|
|
C6H12N2O2
|
(1R)-N-(2,4-Dimethylphenyl)-1,2,3,4,4a,5,6,7,8,9,10,10a-dodecahydro-7-isopropyl-1,4a-dimethylphenanthrene-1α-carboxamide
|
|
|
|
(R)-N,α-Dimethylcyclohexaneethanamine
|
|
|
|
(3R)-N-(2,2-Dimethylpropylidene)-3-[[(3R)-2-phenylhexahydro-1H-pyrrolo[1,2-c]imidazol]-3α-yl]-D-glutamic acid dimethyl ester
|
|
|
|
(R)-N-(1,1-Dimethyl-3-phenylpropyl)-2-hydroxy-2-(3,4-dihydroxy-2-methoxyphenyl)ethanamine
|
|
|
C20H27NO4
|
(2R)-N-(2,6-Dimethylphenyl)-2-[ethyl(propyl)amino]butyramide
|
|
|
C17H28N2O
|
[R,(+)]-N-[2-(Dimethylsulfamoyl)ethyl]-2,4-dihydroxy-3,3-dimethylbutyramide
|
|
|
C10H22N2O5S
|
[αR,(+)]-N,α-Dimethyl-N-[(E)-1-propenyl]benzenemethanamine
|
|
|
|
(1R)-N-(3,4-Dimethylphenyl)-1,2,3,4,4a,5,6,7,8,9,10,10a-dodecahydro-7-isopropyl-1,4a-dimethylphenanthrene-1α-carboxamide
|
|
|
|
(33R)-N1-[3-(Dimethylsulfonio)propyl]bleomycinamide
|
|
|
|
(1R)-N-(2,6-Dimethylphenyl)-7-isopropyl-1,4a-dimethyltetradecahydrophenanthrene-1α-carboxamide
|
|
|
|
(1R,1α,2β,3α,4α)-N,3-Dimethylbicyclo[2.2.1]heptane-2-amine
|
|
|
|
(αR)-N,α-Dimethyl-N-[(1S,2S)-2β-(1-pyrrolidinyl)cyclohexan-1α-yl]benzo[b]thiophene-4-acetamide
|
|
|
|
(2R)-N-(2,6-Dimethylphenyl)-2-aminopropanamide
|
|
53984-26-2
|
C11H16N2O
|
(1R)-N-(2,6-Dimethylphenyl)-1,2,3,4,4a,5,6,7,8,9,10,10a-dodecahydro-7-isopropyl-1,4a-dimethylphenanthrene-1α-carboxamide
|
|
|
|
(R)-(-)-N-(3,5-DINITROBENZOYL)-ALPHA-PHENYLGLYCINE
|
(R)-N-3,5-二硝基苯甲酰基苯甘氨酸
|
74927-72-3
|
C15H11N3O7
|
(R)-(-)-N-(3,5-DINITROBENZOYL)-ALPHA-PHENYLETHYLAMINE
|
R-(-)-3,5-二硝基-N-(1-苯基乙基)苄胺
|
69632-32-2
|
C15H13N3O5
|
(R)-N-(2,5-dioxotetrahydrofuran-3-yl)-2-phenoxyacetamide
|
(R)-N-(2,5-二氧代四氢呋喃-3-基)-2-苯氧基乙酰胺
|
4515-22-4
|
C12H11NO5
|
(R)-N-(2,5-dioxotetrahydrofuran-3-yl)-2-phenoxyacetamide
|
(1-甲基-2,5-二氧代吡咯烷-3-基)氨基甲酸-(R)-苄酯
|
67513-63-7
|
C12H11NO5
|
[R,(-)]-2,N-Diphenylhexanamide
|
|
|
C18H21NO
|
[R,(-)]-2,N-Diphenylsuccinamidic acid
|
|
|
|
(2R)-N-[2-(Diphenylmethoxy)ethyl]-N-methyl-1-phenoxy-2-propanamine
|
|
|
C25H29NO2
|
[R,(-)]-3,N-Diphenylvaleramide
|
|
|
C17H19NO
|
(2R)-N,2-Diphenylpropionamide
|
|
|
C15H15NO
|
(1R)-N,1-Diphenyl-2-(phenylsulfinyl)ethanamine
|
|
|
C20H19NOS
|
[R,(+)]-N-(Diphenylmethylene)-(1-2H)neopentylamine
|
|
|
|
[R,(-)]-2,N-Diphenylvaleramide
|
|
|
C17H19NO
|
[R,(-)]-2,N-Diphenylheptanamide
|
|
|
C19H23NO
|
[R,(-)]-3,N-Diphenylbutyramide
|
|
|
C16H17NO
|
[R,(+)]-2-(m-Nitrophenyl)propionic acid sodium salt
|
|
|
C9H8NNaO4
|
[R,(+)]-2-(m-Nitrophenoxy)propionic acid
|
|
|
C9H9NO5
|
[R,(-)]-2-(m-Nitrophenyl)propionic acid methyl ester
|
|
|
C10H11NO4
|
[R,(-)]-m-Nitrohydratropic acid
|
|
|
C9H9NO4
|
RneasyProtectMidiKit(10)
|
|
|
|
RneasyFibrousTissueMidiKit(10)
|
|
|
|
RneasyMiniKit(50)
|
RNEASY MINI KIT (50)(特价产品)
|
|
|
RneasyMaxiKit(12)
|
|
|
|
RneasyMineluteCleanupKit(50)
|
|
|
|
Rneasy96UniversalTissueKit(4)
|
|
|
|
RneasyProtectMidiKit(50)
|
|
|
|
RneasyMidiKit(10)
|
|
|
|
Rneasy96Kit(4)
|
|
|
|
RneasyLipidTissueMidiKit(10)
|
|
|
|
RneasyPlantMiniKit(20)
|
|
|
|
Rneasy96UniversalTissueKit(12)
|
|
|
|
RneasyPlantMiniKit(50)
|
|
|
|